Enveric Biosciences Inc. (ENVB)
Enveric Biosciences Statistics
Share Statistics
Enveric Biosciences has 10.39M shares outstanding. The number of shares has increased by 39.43% in one year.
| Shares Outstanding | 10.39M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 14.01% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 9.50M |
| Failed to Deliver (FTD) Shares | 160 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 330.22K, so 3.25% of the outstanding shares have been sold short.
| Short Interest | 330.22K |
| Short % of Shares Out | 3.25% |
| Short % of Float | 3.55% |
| Short Ratio (days to cover) | 0.31 |
Valuation Ratios
The PE ratio is -162.32 and the forward PE ratio is -0.31.
| PE Ratio | -162.32 |
| Forward PE | -0.31 |
| PS Ratio | 0 |
| Forward PS | 0.3 |
| PB Ratio | 1.43 |
| P/FCF Ratio | -0.2 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Enveric Biosciences Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.
| Current Ratio | 1.53 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -4435.93 |
Financial Efficiency
Return on equity (ROE) is -0.01% and return on capital (ROIC) is -842.19%.
| Return on Equity (ROE) | -0.01% |
| Return on Assets (ROA) | 0% |
| Return on Capital (ROIC) | -842.19% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.47K |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 28.91K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -65.56% in the last 52 weeks. The beta is 0.47, so Enveric Biosciences 's price volatility has been higher than the market average.
| Beta | 0.47 |
| 52-Week Price Change | -65.56% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 38.34 |
| Average Volume (20 Days) | 509.17K |
Income Statement
| Revenue | n/a |
| Gross Profit | -408.03K |
| Operating Income | -16.45M |
| Net Income | -17.29K |
| EBITDA | -16.85M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -8.09 |
Balance Sheet
The company has 2.29M in cash and 0 in debt, giving a net cash position of 2.29M.
| Cash & Cash Equivalents | 2.29M |
| Total Debt | 0 |
| Net Cash | 2.29M |
| Retained Earnings | -96.50M |
| Total Assets | 4.79M |
| Working Capital | 3.50M |
Cash Flow
In the last 12 months, operating cash flow was -14.09M and capital expenditures -5.18K, giving a free cash flow of -14.10M.
| Operating Cash Flow | -14.09M |
| Capital Expenditures | -5.18K |
| Free Cash Flow | -14.10M |
| FCF Per Share | -6.53 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENVB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2609.68% |
| FCF Yield | -444.4% |
Analyst Forecast
The average price target for ENVB is $10, which is 3125.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 3125.8% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jul 15, 2022. It was a backward split with a ratio of 1:50.
| Last Split Date | Jul 15, 2022 |
| Split Type | backward |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | -34.14 |
| Piotroski F-Score | 3 |